About Cellerys
Cellerys is a company based in Schlieren (Switzerland) founded in 2015. It operates as a B2B. Cellerys offers products and services including Immune Tolerance Solutions and RED4MS Project. Cellerys operates in a competitive market with competitors including QurAlis, Pheno Therapeutics, Frequency Therapeutics, TeraImmune and Altheia Science, among others.
- Headquarter Schlieren, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Cellerys Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellerys
Cellerys offers a comprehensive portfolio of products and services, including Immune Tolerance Solutions and RED4MS Project.
Provides research and development for immune tolerance in health applications
Focuses on immune tolerance advancements for medical science projects
Funding Insights of Cellerys
Detailed funding history for Cellerys
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellerys
Investment portfolio details for Cellerys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellerys
Detailed financials for Cellerys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellerys Comparisons
Peer comparison for Cellerys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellerys
Cellerys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QurAlis, Pheno Therapeutics, Frequency Therapeutics, TeraImmune and Altheia Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs and CSF devices are developed for ALS treatment.
|
|
| Locked | Locked | Locked |
Remyelinating therapies for multiple sclerosis are developed.
|
|
| Locked | Locked | Locked |
Regenerative therapeutics for reversing hearing loss are developed.
|
|
| Locked | Locked | Locked |
T-cell therapies for treating various diseases are developed by TeraImmune.
|
|
| Locked | Locked | Locked |
Stem cell-based therapeutics for cancer and autoimmune diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of stem cell therapy for the treatment of multiple sclerosis
|
Detailed competitors of Cellerys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellerys
Complete news archive for Cellerys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellerys
Cellerys was founded in 2015.
Cellerys is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
Cellerys AG is a biotechnology company based in Switzerland, focusing on immune tolerance research and development. They conduct projects like RED4MS to advance scientific applications in health sciences. The company aims to enhance lives through innovative solutions in medical research, collaborating with partners in the biotech sector while operating from Schlieren.
Cellerys's top competitors include QurAlis, Pheno Therapeutics and Frequency Therapeutics.
Cellerys offers Immune Tolerance Solutions and RED4MS Project.